뉴스벤징가
Xenon Pharmaceuticals Announces Voluntarily Initiated A Temporary Pause Of Enrollment Of New Patients In Ongoing Psychiatry Studies Following Neuropsychiatric Adverse Events; Patients Currently Enrolled In The Ongoing Studies Remain Active
· 발표
기사 요약
자세한 내용은 원문에서 확인해 주세요.
기사 원문에서 발췌했어요.
댓글 —
댓글을 불러오고 있어요…